• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆外泌体分数和低密度脂蛋白胆固醇作为 COVID-19 致死结局的预测因子。

Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19.

机构信息

Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre «Kurchatov Institute», Gatchina, Russia.

Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russia.

出版信息

PLoS One. 2023 Feb 9;18(2):e0278083. doi: 10.1371/journal.pone.0278083. eCollection 2023.

DOI:10.1371/journal.pone.0278083
PMID:36758022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9910704/
Abstract

Transcriptomic analysis conducted by us previously revealed upregulation of genes involved in low-density lipoprotein particle receptor (LDLR) activity pathway in lethal COVID-19 caused by SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Last data suggested the possible role of extracellular vesicles in COVID-19 pathogenesis. The aim of the present study was to retrospectively evaluate parameters of cholesterol metabolism and newly identified EVs, exomeres, as possible predictors of fatal outcome of COVID-19 patients infected by the Alpha and the Delta variants of SARS-CoV-2 virus. Blood from 67 patients with severe COVID-19 were collected at the time of admission to the intensive care unit (ICU) and 7 days after admission to the ICU. After 30 days patients were divided into two subgroups according to outcome-34 non-survivors and 33 survivors. This study demonstrated that plasma low- and high-density lipoprotein cholesterol levels (LDL-C and HDL-C) were decreased in non-survivors compared to controls at the time of admission to the ICU. The conjoint fraction of exomeres and LDL particles measured by dynamic light scattering (DLS) was decreased in non-survivors infected by the Alpha and the Delta variants compared to survivors at the time of admission to the ICU. We first showed that reduction of exomeres fraction may be critical in fatal outcome of COVID-19.

摘要

我们之前进行的转录组分析显示,在由 SARS-CoV-2 病毒(严重急性呼吸综合征冠状病毒 2)引起的致死性 COVID-19 中,参与低密度脂蛋白颗粒受体 (LDLR) 活性途径的基因上调。最新数据表明,细胞外囊泡可能在 COVID-19 发病机制中发挥作用。本研究的目的是回顾性评估胆固醇代谢参数和新发现的 EVs(外切体)作为 SARS-CoV-2 病毒的 Alpha 和 Delta 变体感染 COVID-19 患者致命结局的可能预测因子。在入住重症监护病房 (ICU) 时和入住 ICU 后 7 天,采集了 67 名重症 COVID-19 患者的血液。30 天后,根据患者的预后将患者分为两组-34 名非幸存者和 33 名幸存者。本研究表明,与对照组相比,入住 ICU 时非幸存者的血浆低和高密度脂蛋白胆固醇水平(LDL-C 和 HDL-C)降低。与幸存者相比,入住 ICU 时感染 Alpha 和 Delta 变体的非幸存者的外切体和 LDL 颗粒的联合分数(通过动态光散射 (DLS) 测量)降低。我们首次表明,外切体分数的降低可能是 COVID-19 致命结局的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/a1b2dee26d8a/pone.0278083.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/439006bc11a4/pone.0278083.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/327bcdb03d4e/pone.0278083.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/a1b2dee26d8a/pone.0278083.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/439006bc11a4/pone.0278083.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/327bcdb03d4e/pone.0278083.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dda/9910704/a1b2dee26d8a/pone.0278083.g003.jpg

相似文献

1
Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19.血浆外泌体分数和低密度脂蛋白胆固醇作为 COVID-19 致死结局的预测因子。
PLoS One. 2023 Feb 9;18(2):e0278083. doi: 10.1371/journal.pone.0278083. eCollection 2023.
2
Is there any association between plasma lipid profile and severity of COVID-19?血浆脂质谱与 COVID-19 的严重程度之间是否存在关联?
Clin Nutr ESPEN. 2022 Jun;49:191-196. doi: 10.1016/j.clnesp.2022.04.026. Epub 2022 Apr 28.
3
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.低高密度脂蛋白水平与 COVID-19 患者的严重程度相关:一项观察性研究。
Lipids Health Dis. 2020 Sep 7;19(1):204. doi: 10.1186/s12944-020-01382-9.
4
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19.低密度脂蛋白胆固醇水平与 COVID-19 的不良临床结局相关。
Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2619-2627. doi: 10.1016/j.numecd.2021.06.016. Epub 2021 Jul 6.
5
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
6
High-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU.高密度脂蛋白胆固醇与低密度脂蛋白胆固醇比值在 ICU 收治的急性胰腺炎患者早期评估疾病严重程度和预后中的作用。
BMC Gastroenterol. 2020 May 27;20(1):164. doi: 10.1186/s12876-020-01315-x.
7
Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.白细胞与高密度脂蛋白胆固醇比值对 COVID-19 患者及糖尿病亚组的预后价值。
Front Endocrinol (Lausanne). 2021 Sep 13;12:727419. doi: 10.3389/fendo.2021.727419. eCollection 2021.
8
Lipid metabolism changes in patients with severe COVID-19.严重 COVID-19 患者的脂代谢变化。
Clin Chim Acta. 2021 Jun;517:66-73. doi: 10.1016/j.cca.2021.02.011. Epub 2021 Feb 24.
9
Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants.作为 COVID-19 发病症状和 COVID-19 后症状的头痛,在感染武汉、阿尔法或德尔塔 SARS-CoV-2 变异株的住院 COVID-19 幸存者中。
Headache. 2022 Oct;62(9):1148-1152. doi: 10.1111/head.14398. Epub 2022 Sep 16.
10
HDL cholesterol levels and susceptibility to COVID-19.高密度脂蛋白胆固醇水平与 COVID-19 的易感性。
EBioMedicine. 2022 Aug;82:104166. doi: 10.1016/j.ebiom.2022.104166. Epub 2022 Jul 15.

引用本文的文献

1
Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.感染新冠病毒德尔塔变异株的存活患者与非存活患者之间差异表达的转录组分析。
Sci Rep. 2025 May 15;15(1):16844. doi: 10.1038/s41598-025-00280-3.
2
CD66b/CD68 circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection.CD66b/CD68 循环细胞外囊泡、乳酸脱氢酶和中性粒细胞与淋巴细胞比值可区分感染期间和感染后 2019 年冠状病毒病的严重程度。
J Extracell Vesicles. 2024 Jul;13(7):e12456. doi: 10.1002/jev2.12456.
3

本文引用的文献

1
Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.先天和适应性细胞因子在 COVID-19 患者生存中的作用。
Int J Mol Sci. 2022 Sep 7;23(18):10344. doi: 10.3390/ijms231810344.
2
Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis.脓毒症期间肝功能障碍、脂蛋白浓度与死亡率的关系。
PLoS One. 2022 Aug 22;17(8):e0272352. doi: 10.1371/journal.pone.0272352. eCollection 2022.
3
Extracellular Particles as Carriers of Cholesterol Not Associated with Lipoproteins.作为不与脂蛋白相关的胆固醇载体的细胞外颗粒。
Cholesterol and COVID-19-therapeutic opportunities at the host/virus interface during cell entry.
胆固醇与 COVID-19——细胞进入过程中宿主/病毒界面的治疗机会。
Life Sci Alliance. 2024 Feb 22;7(5). doi: 10.26508/lsa.202302453. Print 2024 May.
Membranes (Basel). 2022 Jun 14;12(6):618. doi: 10.3390/membranes12060618.
4
Coronavirus Infection and Cholesterol Metabolism.冠状病毒感染与胆固醇代谢。
Front Immunol. 2022 Apr 21;13:791267. doi: 10.3389/fimmu.2022.791267. eCollection 2022.
5
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.循环 ACE2 表达的细胞外囊泡可阻断多种 SARS-CoV-2 株。
Nat Commun. 2022 Jan 20;13(1):405. doi: 10.1038/s41467-021-27893-2.
6
Transcriptomic Profiles Reveal Downregulation of Low-Density Lipoprotein Particle Receptor Pathway Activity in Patients Surviving Severe COVID-19.转录组谱揭示重症 COVID-19 幸存者中低密度脂蛋白颗粒受体途径活性下调。
Cells. 2021 Dec 10;10(12):3495. doi: 10.3390/cells10123495.
7
The Delta Variant Mutations in the Receptor Binding Domain of SARS-CoV-2 Show Enhanced Electrostatic Interactions with the ACE2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域中的德尔塔变异突变显示出与血管紧张素转换酶2(ACE2)增强的静电相互作用。
Med Drug Discov. 2021 Dec 4:100114. doi: 10.1016/j.medidd.2021.100114.
8
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.超级膜是充满疾病生物标志物和治疗靶点的功能性细胞外纳米颗粒。
Nat Cell Biol. 2021 Dec;23(12):1240-1254. doi: 10.1038/s41556-021-00805-8. Epub 2021 Dec 9.
9
Lipid peroxidation as a hallmark of severity in COVID-19 patients.脂质过氧化作为新冠病毒肺炎患者病情严重程度的一个标志。
Redox Biol. 2021 Nov 6;48:102181. doi: 10.1016/j.redox.2021.102181.
10
Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation.需要体外膜肺氧合的患者的脂蛋白浓度。
Sci Rep. 2021 Aug 26;11(1):17225. doi: 10.1038/s41598-021-96728-3.